BridgeMD
New treatment option for Shoulder Instability
Official title Virtual Reality Rehabilitation for Shoulder Pathologies
ClinicalTrials.gov ID: NCT06963983
What this study is testing
- What it's testing
- Most rehabilitation protocols require patients to train the affected limbs with high regularity, following repetitive cycles of exercises, in order to recover mobility and strength. Nonetheless, the repetitive nature of these exercises can demotivate patients leading to less intense and committed training, if not ending with a lack of compliance toward the prescribed exercises, ultimately leading to a suboptimal recovery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients able to understand the content of the patient information / consent form and give consent to take part in the research project
- Glenohumeral instability surgical treated with traumatic initial instability in a \ 15-20%), bipolar bone-loss resulting in "off-track" lesion
- Partial or complete rotator cuff repair with an indication to postoperative rehabilitation depending on surgeon recommendation
- Idiopathic, primary, or secondary frozen shoulder
You likely can't join if
- Patients with a language barrier hindering questionnaires completion
- Patients unlikely to attend clinical follow-up (e.g. when living abroad)
- Legal incompetence
- Enrolment of the investigators, his/her family members, employees and other dependent persons
- Non-motivated patients
- Active infection
See the full eligibility criteria
- Adult patients able to understand the content of the patient information / consent form and give consent to take part in the research project
- Glenohumeral instability surgical treated with traumatic initial instability in a \ 15-20%), bipolar bone-loss resulting in "off-track" lesion
- Partial or complete rotator cuff repair with an indication to postoperative rehabilitation depending on surgeon recommendation
- Idiopathic, primary, or secondary frozen shoulder
- Patients with a language barrier hindering questionnaires completion
- Patients unlikely to attend clinical follow-up (e.g. when living abroad)
- Legal incompetence
- Enrolment of the investigators, his/her family members, employees and other dependent persons
- Non-motivated patients
- Active infection
- Exclusion criteria related to glenohumeral instability: uncontrolled epilepsy, spontaneous unidirectional instability in a hyperlax patient, multidirectional instability, elher-Danlos syndrome
- Exclusion criteria related to rotator cuff tears: Additional procedure(s) (muscle transfer, patch,…)
- Exclusion criteria related to VR use: Patients with a predisposition to motion sickness, Patients suffering from epilepsy or having any serious mental illness (schyzophrenia, neurological problems, etc.), Patients with...
The study team makes the final eligibility decision.
Where it's taking place
- Meyrin, Canton of Geneva, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Meyrin, Canton of Geneva, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.